Skip to main content
SpringerLink
Log in

CYP2D6 genetic variation in Ugandans

  • Letter to the Editor
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Availability of data and material

The detailed methods and the photos of electrophoresis after XL-PCR and PCR–RFLP assays will be provided on reasonable request.

References

  1. Jarvis JP, Peter AP, Shaman JA (2019) Consequences of CYP2D6 copy-number variation for pharmacogenomics in psychiatry. Front Psychiatry 10:432. https://doi.org/10.3389/fpsyt.2019.00432

    Article  PubMed  PubMed Central  Google Scholar 

  2. Taylor C, Crosby I, Yip V, Maguire P, Pirmohamed M, Turner RM (2020) A Review of the important role of CYP2D6 in pharmacogenomics. Genes (Basel) 11(11). https://doi.org/10.3390/genes11111295

  3. Nofziger C, Turner AJ, Sangkuhl K, Whirl-Carrillo M, Agundez JAG, Black JL, Dunnenberger HM, Ruano G, Kennedy MA, Phillips MS, Hachad H, Klein TE, Gaedigk A (2020) PharmVar GeneFocus: CYP2D6. Clin Pharmacol Ther 107(1):154–170. https://doi.org/10.1002/cpt.1643

    Article  CAS  PubMed  Google Scholar 

  4. Gene-specific Information Tables for CYP2D6. https://www.pharmgkb.org/page/cyp2d6RefMaterials

  5. Dorado P, Caceres MC, Pozo-Guisado E, Wong ML, Licinio J, Llerena A (2005) Development of a PCR-based strategy for CYP2D6 genotyping including gene multiplication of worldwide potential use. Biotechniques 39(4):571–574

    Article  Google Scholar 

  6. Gaedigk A, Ryder DL, Bradford LD, Leeder JS (2003) CYP2D6 poor metabolizer status can be ruled out by a single genotyping assay for the -1584G promoter polymorphism. Clin Chem 49(6 Pt 1):1008–1011. https://doi.org/10.1373/49.6.1008

    Article  CAS  PubMed  Google Scholar 

  7. Gaedigk A, Gotschall RR, Forbes NS, Simon SD, Kearns GL, Leeder JS (1999) Optimization of cytochrome P4502D6 (CYP2D6) phenotype assignment using a genotyping algorithm based on allele frequency data. Pharmacogenetics 9(6):669–682. https://doi.org/10.1097/01213011-199912000-00002

    Article  CAS  PubMed  Google Scholar 

  8. PharmVar CYP2D6 gene page. https://www.pharmvar.org/gene/CYP2D6

  9. Caudle KE, Sangkuhl K, Whirl-Carrillo M, Swen JJ, Haidar CE, Klein TE, Gammal RS, Relling MV, Scott SA, Hertz DL, Guchelaar HJ, Gaedigk A (2020) Standardizing CYP2D6 genotype to phenotype translation: consensus recommendations from the Clinical Pharmacogenetics Implementation Consortium and Dutch Pharmacogenetics Working Group. Clin Transl Sci 13(1):116–124. https://doi.org/10.1111/cts.12692

    Article  PubMed  Google Scholar 

Download references

Funding

This study was supported by the Fund for the Promotion of International Scientific Research.

Author information

Authors and Affiliations

  1. Department of Neuropsychiatry, Hirosaki University Graduate School of Medicine, Hirosaki, Japan

    Jun Miura & Sunao Kaneko

  2. Department of Clinical Pharmacology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan

    Jun Miura & Tomonori Tateishi

  3. Department of Pharmacology and Therapeutics, Faculty of Medicine, Mbarara University of Science and Technology, Mbarara, Uganda

    Celestino Obua

  4. Department of Psychiatry, College of Health Sciences, Makerere University, Kampala, Uganda

    Catherine Abbo

Authors
  1. Jun Miura
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Celestino Obua
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Catherine Abbo
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Tomonori Tateishi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Sunao Kaneko
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jun Miura.

Ethics declarations

Ethics approval (include appropriate approvals or waivers)

The study was approved by the ethics committees of the Hirosaki University Graduate School of Medicine, and of the Makerere University Faculty of Medicine.

Consent to participate

All participants provided written informed consent on the basis of verbal and written information.

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Miura, J., Obua, C., Abbo, C. et al. CYP2D6 genetic variation in Ugandans. Eur J Clin Pharmacol 78, 155–157 (2022). https://doi.org/10.1007/s00228-021-03208-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00228-021-03208-8

Keywords

Search

Navigation